MedAdvisor off and running, page-47

@glyco @McDuff
Day 1 relisted on the ASX.
I share your concerns; revenue is low relative to market cap but it's still at an early stage.


MDR revenue is currently made up of:
-Pharmacies paying a monthly fee to offer MedAdvisor
-Drug makers paying MedAdvisor a fee to deliver messages to patients
-They can also advertise on the MedAdvisor platform (which I'm sure we will see more of in 2016 - drug makers, Medibank, Bupa, pharmacies, doctor clinics etc.)

It's still at an early stage- available at 25% of Australian pharmacies and used by only 100,000 Australians. Clear room for growth. 500,000 Australian and 50% of pharmacies the next target. Onwards and upwards I say!